These results implied that miR-765 overexpression or inhibition was completely ineffective in BRD4 KO ovarian cancer cells, again confirming that BRD4 silencing caused miR-765-induced anti-ovarian cancer cell activity. The gene discussed is BRD4; the disease is ovarian carcinoma.